Active Ingredient: CHOLINE FENOFIBRATE
Proprietary Name: TRILIPIX
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 135MG FENOFIBRIC ACID
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022224
Product Number: 002
Approval Date: Dec 15, 2008
Applicant Holder Full Name: ABBVIE INC
Marketing Status:
Prescription
Patent and Exclusivity Information